206 related articles for article (PubMed ID: 26556999)
1. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.
Kleist B; Poetsch M
World J Gastroenterol; 2015 Nov; 21(41):11740-7. PubMed ID: 26556999
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in sporadic CRC and hereditary nonpolyosis colorectal cancer.
Sun MH
Dis Markers; 2004; 20(4-5):283-8. PubMed ID: 15528794
[TBL] [Abstract][Full Text] [Related]
4. ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
Jardé T; Kass L; Staples M; Lescesen H; Carne P; Oliva K; McMurrick PJ; Abud HE
PLoS One; 2015; 10(9):e0138336. PubMed ID: 26367378
[TBL] [Abstract][Full Text] [Related]
5. Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer.
Jezkova J; Williams JS; Pinto F; Sammut SJ; Williams GT; Gollins S; McFarlane RJ; Reis RM; Wakeman JA
Oncotarget; 2016 Mar; 7(10):11478-86. PubMed ID: 26862851
[TBL] [Abstract][Full Text] [Related]
6. Origin and maintenance of the intestinal cancer stem cell.
Davies EJ; Marsh V; Clarke AR
Mol Carcinog; 2011 Apr; 50(4):254-63. PubMed ID: 21465575
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of colorectal neuroendocrine cell tumor].
Higuchi T; Sugihara K
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):152-6. PubMed ID: 18536319
[TBL] [Abstract][Full Text] [Related]
8. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
9. Endocrine tumours of the hindgut.
Vogelsang H; Siewert JR
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):739-51. PubMed ID: 16253898
[TBL] [Abstract][Full Text] [Related]
10. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.
Thanasupawat T; Hammje K; Adham I; Ghia JE; Del Bigio MR; Krcek J; Hoang-Vu C; Klonisch T; Hombach-Klonisch S
Oncol Rep; 2013 Jan; 29(1):149-54. PubMed ID: 23128569
[TBL] [Abstract][Full Text] [Related]
11. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.
Conteduca V; Aieta M; Amadori D; De Giorgi U
Crit Rev Oncol Hematol; 2014 Oct; 92(1):11-24. PubMed ID: 24952997
[TBL] [Abstract][Full Text] [Related]
16. Cellular Interactions in the Intestinal Stem Cell Niche.
Pastuła A; Marcinkiewicz J
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):19-26. PubMed ID: 30242440
[TBL] [Abstract][Full Text] [Related]
17. Specific cell differentiation in breast cancer: a basis for histological classification.
Rakha E; Toss M; Quinn C
J Clin Pathol; 2022 Feb; 75(2):76-84. PubMed ID: 34321225
[TBL] [Abstract][Full Text] [Related]
18. Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors.
Ashley N; Yeung TM; Bodmer WF
Cancer Res; 2013 Sep; 73(18):5798-809. PubMed ID: 23867471
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
